NUT MIDLINE CARCINOMA

NUT MIDLINE CARCINOMA was reported 6 times

NUT MIDLINE CARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Histone Deacetylase Inhibitor [EPC] 1 0.0003
1 Topoisomerase Inhibitor [EPC] 3 0.0000
2 Microtubule Inhibitor [EPC] 4 0.0000
3 HER2/neu Receptor Antagonist [EPC] 1 0.0000
4 Alkylating Drug [EPC] 3 0.0000
5 Platinum-based Drug [EPC] 3 0.0000